Top of page Skip navigation

 Genesis Sessions 2018



08.00 - Registration

09.00 - Welcome from One Nucleus

09.15 - Winners and Losers 2018
Mike Ward, Pharma Intelligence & Datamonitor

09.40 - Keynote Presentation
Speaker tbc

10.05 - Plenary Debate – Is Convergence Driving Investment Syndicates?

With more of the technology and life science worlds coming together, how is this being reflected in the investment community? With the potential to disrupt the traditional syndicates and investment trends, convergence may significantly impact who is investing with whom. Our panellists will discuss how investment partners are being attracted in this rapidly changing dynamic.
Eric Elenko, PureTech Health

10.55 - Closing Remarks

11.00 - Coffee Break

11.30 - Parallel Leadership Sessions 1

      - Convergence through Deals - Case Study 1

      - Digital Bio-convergence - How are Smart Devices Enabling Clinical Development Outside of the Hospital Setting
Nigel Whittle, Plextek
Paul Winter, TTP

       - Convergence of Academia and Business - The Evolving Models of R&D Collaboration
Richard Butt, Apollo Therapeutics
Mark Samuels, Medicines Discovery Catapult
Steven Klein, IRICoR

       - Convergence to Increase Productivity - Is Machine Learning a Game Changer in CNS Discovery?
Rabia Khan, BenevolentAI

12.30 -Lunch

Including a panel discussion and the announcement of the winner of the BioNewsRound Award

14.00 - Parallel Leadership Sessions 2

      - Convergence through Deals - Case Study 2

      - Digital Bio-convergence - Diagnostics and Cognitive Monitoring for Dementia Patients
David Walker, Philips Research Laboratories
Peter Jarritt, National Institute for Health Research

       - Convergence of Academia and Business - Commercialising Multi-Disciplinary Research

      - Convergence to Increase Productivity - Synthetic Biology for Enhanced Drug Design
Tim Brears, Evonetix

15.00 -Coffee Break

15.20 - BioFinance Briefing: What works in the London Capital Markets?
James Clark, London Stock Exchange

16.00 - Parallel Leadership Sessions 3

      - Convergence through Deals - Case Study 3

      - Digital Bio-convergence - Improving Detection and Compliance in Respiratory Disorders
Peter Ferguson, ARM
Collette Johnson, Bespak
Rene van der Merwe, MedImmune

       - Convergence of Academia and Business - Where is the Best Incubation Environment: Academia or Industry?
Keith Powell, Canbex Therapeutics
Pascal Longchamp, Scarab Genomics
Daniel Green, Yaqrit

      - Convergence to Increase Productivity - Leveraging the Power of the Microbiome
Christian Roghi, Quadram Institute 

 17.05 – 18.00 - Plenary Debate – What will be the highlights of 2019?

Opinion leaders from the sector will discuss what they perceive as being the main trends in developments to watch out for in the coming year.

18.00 – 18.05 - Closing Remarks and prize draw

18.05 – 19.15 - Drinks Reception